Filtered By:
Specialty: Cardiology
Source: European Heart Journal
Condition: Stroke
This page shows you your search results in order of relevance. This is page number 19.
Order by Relevance | Date
Total 328 results found since Jan 2013.
Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial
ConclusionIn patients with stable coronary heart disease, higher visit-to-visit variabilities of both systolic and diastolic BP are strong predictors of increased risk of cardiovascular events, independently of mean BP.
Source: European Heart Journal - May 27, 2017 Category: Cardiology Source Type: research
Effects of noise on vascular function, oxidative stress, and inflammation: mechanistic insight from studies in mice
ConclusionWe established a novel and unique aircraft noise stress model with increased blood pressure and vascular dysfunction associated with oxidative stress. This animal model enables future studies of molecular mechanisms, mitigation strategies, and pharmacological interventions to protect from noise-induced vascular damage.
Source: European Heart Journal - February 17, 2017 Category: Cardiology Source Type: research
Uncommon cause of dyspnoea after percutaneous closure of the left atrial appendage
A 69-year-old female with persistent atrial fibrillation and history of recurrent strokes presented with progressive shortness of breath. Three years ago, percutaneous closure of the left atrial appendage (LAA) for stroke prophylaxis was performed using an Amplatzer Amulet® device (St. Jude Medical, MN, USA).
Source: European Heart Journal - August 1, 2017 Category: Cardiology Source Type: research
Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
ConclusionsTransthyretin cardiac amyloidosis is prevalent in 16% of patients with severe calcific AS undergoing TAVR and is associated with a severe AS phenotype of low-flow low-gradient with mildly reduced ejection fraction. Average tissue Doppler mitral annular S ’ of < 6 cm/s may be a sensitive measure that should prompt a confirmatory99mTc-PYP scan and subsequent testing for ATTR-CA. Prospective assessment of outcomes after TAVR is needed in patients with and without ATTR-CA.
Source: European Heart Journal - August 1, 2017 Category: Cardiology Source Type: research
Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995–2014
ConclusionGradual implementation of new and established evidence-based treatments in STEMI patients during the last 20 years has been associated with prolonged survival and lower risk of recurrent ischaemic events, although a plateauing is seen since around 2008.
Source: European Heart Journal - August 29, 2017 Category: Cardiology Source Type: research
Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study
ConclusionA switched DAPT is superior to an unchanged DAPT strategy to prevent bleeding complications without increase in ischaemic events following ACS.
Source: European Heart Journal - May 16, 2017 Category: Cardiology Source Type: research
A Swiss National Strategy for 2017 –2024
A Swiss National Strategy for Cardiovascular disease, Stroke, and Diabetes for the next 7 years has been produced through a joint initiative of 26 National Cardiovascular Societies and the Swiss Heart Foundation
Source: European Heart Journal - November 7, 2017 Category: Cardiology Source Type: research
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
ConclusionAt one year, clinical outcomes with the SYNTAX-II strategy were associated with improved clinical results compared to the PCI performed in comparable patients from the original SYNTAX-I trial. Longer term follow-up is awaited and a randomized clinical trial with contemporary CABG is warranted.ClinicalTrials.gov IdentifierNCT02015832
Source: European Heart Journal - August 26, 2017 Category: Cardiology Source Type: research
Safety and efficacy of a repositionable and fully retrievable aortic valve used in routine clinical practice: the RESPOND Study
ConclusionThe results of RESPOND confirm the safety and efficacy of TAVI with the Lotus Valve in routine clinical practice.Trial registrationClinicalTrials.gov #NCT 02031302.
Source: European Heart Journal - June 22, 2017 Category: Cardiology Source Type: research
Foreign body granuloma as an unexpected long-term finding after percutaneous closure of a patent foramen ovale
A 67-year-old man was referred to our hospital for catheter ablation of atrial fibrillation. Eight years earlier, prior to diagnosis of atrial fibrillation, the patient suffered an ischaemic stroke. A patent foramen ovale (PFO) was diagnosed and the patient underwent percutaneous PFO closure by implantation of a Premere device (20 mm, St. Jude Medical). One month ago, the patient had another middle-cerebral artery infarction, which was considered cardioembolic due to insufficient anticoagulation. However, transthoracic echocardiography (TTE) obtained on current admission demonstrated a suspicious mass in the left atrium...
Source: European Heart Journal - March 24, 2017 Category: Cardiology Source Type: research
Cholesterol variability: a marker for increased risk or a risk factor?
This editorial refers to ‘Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study’†, by M.K. Kimet al., on page3560.
Source: European Heart Journal - November 13, 2017 Category: Cardiology Source Type: research
How to use Mendelian randomization to anticipate the results of randomized trials
This editorial refers to ‘Differential effects ofPCSK9 variants on risk of coronary disease and ischaemic stroke ’††, by J.C. Hopewellet al., on page 354.
Source: European Heart Journal - August 16, 2017 Category: Cardiology Source Type: research
An African cardiology summitThe World Heart Federation African Summit on Best Practices in Policy and Access to Care in 2017 concluded with the Khartoum Action Plan, to improve cardiovascular on the African continent
The World Heart Federation (WHF) is the umbrella organization of continental and national cardiac societies and heart foundations globally, reporting to the World Health Organization (WHO). The WHF is dedicated to the global fight against CVD, including heart disease, stroke, and rheumatic heart disease (RHD). Building on the first Global Summit on Circulatory Health, held at the 2016 World Congress of Cardiology and Cardiovascular Health in Mexico City, the second Summit held in Singapore July 2017 focused on building a civil society movement for circulatory health.
Source: European Heart Journal - February 6, 2018 Category: Cardiology Source Type: research
The winding path towards rationale anti-thrombotic therapy to prevent stroke in patients with atrial fibrillation
This editorial refers to ‘Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry’††, by F.W.A. Verheugtet al., on page 464.
Source: European Heart Journal - January 9, 2018 Category: Cardiology Source Type: research
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry
ConclusionPrescribing AP monotherapy in newly diagnosed AF has declined, but even nowadays a substantial proportion of AP-treated patients with AF have no indication for AP.Clinical Trial RegistrationURL:http://www.clinicaltrials.gov. Unique identifier: NCT01090362.
Source: European Heart Journal - December 20, 2017 Category: Cardiology Source Type: research
